ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia‐related changes and normal karyotype

ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia‐related changes and normal karyotype

Abstract Acute myeloid leukemia with myelodysplasia‐related changes (AML‐MRC) are poor outcome leukemias. Its diagnosis is based on clinical, cytogenetic, and cytomorphologic criteria, last criterion being sometimes difficult to assess. A high frequency of ASXL1 mutations have been described in this...

Full description

Bibliographic Details
Main Authors: Concepción Prats‐Martín, Sergio Burillo‐Sanz, Rosario M. Morales‐Camacho, Olga Pérez‐López, Milagros Suito, Maria T. Vargas, Teresa Caballero‐Velázquez, Estrella Carrillo‐Cruz, José González, Ricardo Bernal, José A. Pérez‐Simón
Format: Article
Language:English
Published: Wiley 2020-06-01
Series:Cancer Medicine
Subjects:
AML‐MRC
ASXL1
myelodysplasia
myeloid leukemia
Online Access:https://doi.org/10.1002/cam4.2947

Internet

https://doi.org/10.1002/cam4.2947

Similar Items